David S Ettinger Selected Research

3-chloro-2,5,6-trimethylbenzoate

1/2020

Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Ettinger Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 03/2002
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2002
10	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2002
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2012 - 09/2002
7	Sarcoma (Soft Tissue Sarcoma) 04/2017 - 01/2002
5	Pneumonia (Pneumonitis) 10/2021 - 12/2018
5	Neutropenia 01/2019 - 03/2002
4	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2010
3	Disease Progression 01/2018 - 11/2006
2	Sepsis (Septicemia) 01/2019 - 08/2005
2	Vomiting 01/2017 - 05/2010
2	Nausea 01/2017 - 05/2010
2	Esophagitis 07/2012 - 01/2009
2	Febrile Neutropenia 01/2009 - 08/2004
1	Lung Injury 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Adenocarcinoma of Lung 12/2014
1	Carcinogenesis 12/2014
1	Carcinoid Tumor (Carcinoid) 03/2014
1	Leukemia 07/2012
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 06/2010
1	Thymus Neoplasms (Thymus Neoplasm) 06/2010
1	Cardiotoxicity 05/2010
1	Breast Neoplasms (Breast Cancer) 04/2009
1	Diarrhea 02/2007
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2005
1	Anemia 04/2005
1	Thrombocytopenia (Thrombopenia) 04/2005
1	Fatigue 08/2004
1	Thymoma (Thymic Carcinoma) 01/2004
1	Hematologic Neoplasms (Hematological Malignancy) 03/2003

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 04/2005
5	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2017
5	B7-H1 AntigenIBA 10/2021 - 08/2017
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2002
5	Etoposide (VP 16)FDA LinkGeneric 07/2012 - 04/2005
5	Cisplatin (Platino)FDA LinkGeneric 07/2012 - 08/2004
4	PlatinumIBA 01/2019 - 01/2005
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 05/2005
3	Pharmaceutical PreparationsIBA 01/2018 - 09/2002
3	Pemetrexed (MTA)FDA Link 05/2013 - 03/2002
3	Cetuximab (Erbitux)FDA Link 06/2010 - 04/2005
3	Gemcitabine FDA Link 01/2009 - 01/2002
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2018
2	Bevacizumab (Avastin)FDA Link 01/2019 - 01/2018
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 12/2014
2	Octreotide (Sandostatin)FDA LinkGeneric 06/2010 - 01/2004
2	Prednisone (Sone)FDA LinkGeneric 06/2010 - 01/2004
2	amrubicinIBA 05/2010 - 02/2007
2	Irinotecan (Camptosar)FDA LinkGeneric 02/2007 - 01/2002
2	Docetaxel (Taxotere)FDA Link 04/2005 - 01/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2003 - 03/2002
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	LigandsIBA 12/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	3-chloro-2,5,6-trimethylbenzoateIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 08/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013
1	Itraconazole (Sporanox)FDA LinkGeneric 05/2013
1	SmokeIBA 03/2013
1	vosaroxinIBA 02/2011
1	Topoisomerase II InhibitorsIBA 02/2011
1	AnthracyclinesIBA 02/2011
1	AntiemeticsIBA 04/2009
1	Growth Factor ReceptorsIBA 02/2009
1	Monoclonal AntibodiesIBA 02/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2009
1	temsirolimus FDA Link 09/2008
1	Oxidoreductases (Dehydrogenase)IBA 02/2007
1	quinone (benzoquinone)IBA 02/2007
1	NADP (NADPH)IBA 02/2007
1	EnzymesIBA 02/2007
1	perifosineIBA 11/2006
1	epothilone B (EPO906)IBA 05/2005
1	TubulinIBA 05/2005
1	ixabepilone (BMS 247550)FDA Link 05/2005
1	taxaneIBA 05/2005
1	Epothilones (Epothilone)IBA 05/2005
1	Gefitinib (Iressa)FDA Link 04/2005
1	Alanine Transaminase (SGPT)IBA 08/2004
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2004
1	AntimetabolitesIBA 03/2003
1	Methotrexate (Mexate)FDA LinkGeneric 03/2003
1	Ifosfamide FDA LinkGeneric 09/2002
1	Teniposide (VM 26)FDA Link 09/2002
1	Folic Acid AntagonistsIBA 03/2002
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 03/2002
1	N(1),N(11)-diethylnorspermineIBA 03/2002
1	Antineoplastic Agents (Antineoplastics)IBA 03/2002

Therapy/Procedure

26	Therapeutics 01/2022 - 02/2002
22	Drug Therapy (Chemotherapy) 10/2020 - 01/2002
13	Radiotherapy 01/2019 - 01/2005
9	Immunotherapy 01/2022 - 01/2016
5	Adjuvant Chemotherapy 10/2010 - 04/2005
3	Neoadjuvant Therapy 04/2017 - 02/2006
1	Intravenous Administration 05/2013
1	Surgical Amputation (Amputations) 10/2010
1	Chemoradiotherapy 04/2005